Bhatia, Rakesh
Siddiqui, Jawed Akhtar http://orcid.org/0000-0003-1287-3004
Ganguly, Koelina
Thompson, Christopher M.
Cannon, Andrew
Aithal, Abhijit
Perumal, Naveenkumar
Maurya, Shailendra K.
Li, Xiaoqi
Cox, Jesse L. http://orcid.org/0000-0002-4590-7381
Gurumurthy, Channabasavaiah B. http://orcid.org/0000-0002-8022-4033
Rachagani, Satyanarayana
Jain, Maneesh http://orcid.org/0000-0002-2020-3687
Nasser, Mohd Wasim http://orcid.org/0000-0003-2070-4972
Batra, Surinder K. http://orcid.org/0000-0001-9470-9317
Kumar, Sushil http://orcid.org/0000-0002-2155-3443
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA026428)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA235991, CA210240, CA217798)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Article History
Received: 27 June 2022
Revised: 15 December 2022
Accepted: 19 December 2022
First Online: 9 January 2023
Competing interests
: SKB is a founder of Sanguine Diagnostics and Therapeutics, Inc. Other authors have no competing interests to declare.